LogicBio Therapeutics Inc (NASDAQ:LOGC)
| 0.2725 Delayed Data As of Sep 30 |  -0.0123 / -4.32%Today’s Change | 0.26 Today|||52-Week Range 4.75 | -88.20% Year-to-Date |
Latest LOGC News | Press Releases
| The Zacks Analyst Blog highlights Consolidated Water, Ashford Hospitality Trust, BankFinancial, LogicBio Therapeutics and ProPhase Labs Sep 28 / Zacks.com - Paid Partner Content | 5 Winning Stocks Backed by the Overlooked Trick of Rising P/E Sep 27 / Zacks.com - Paid Partner Content |
| 5 Big Winners as Dollar Strengthens on Fed Rate Hike Sep 27 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.28 |
| Today’s open | 0.27 |
| Day’s range | 0.27 - 0.27 |
| Volume | 2 |
| Average volume (3 months) | 196,738 |
| Market cap | $9.3M |
Data as of 2:03pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | +3.86% |
| Earnings growth (this year) | +35.89% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +56.63% |
| P/E ratio | NM |
| Price/Sales | 13.82 |
| Price/Book | 0.32 |
Competitors
| ---- | ||
| TBGNFOxurion NV | 0.00 | 0.00% |
| PHASPhaseBio Pharmaceuti... | -0.02 | -8.50% |
| KTRAKintara Therapeutics... | -0.01 | -4.74% |
Data as of 4:01pm ET, 09/30/2022
Financials
| Next reporting date | November 14, 2022 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $5.4M |
| Annual profit (last year) | -$40.0M |
| Net profit margin | -739.91% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
